Contract 75D30124D18408
Astrazeneca Pharmaceuticals Lp · Department Of Health And Human Services · September 18, 2024
Astrazeneca Pharmaceuticals Lp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 18, 2024 for $210,000 of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 21, 2024.
Contract details
- PIID
- 75D30124D18408
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 18, 2024
- Latest action
- October 21, 2024
Description
PEDIATRIC FLU VACCINES 2024-2025
Modification timeline
-
October 21, 2024Mod P00003$210.4K
-
September 18, 2024Mod P00002 · Other Administrative Action$12.11M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30124D18408?
Contract 75D30124D18408 is a federal contract awarded to Astrazeneca Pharmaceuticals Lp by Department Of Health And Human Services on September 18, 2024 for $210,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75D30124D18408?
Astrazeneca Pharmaceuticals Lp won contract 75D30124D18408 from Department Of Health And Human Services.
How much is contract 75D30124D18408 worth?
Contract 75D30124D18408 has obligated $210,000 to date.